Safety of HIV medications – new podcast out now

In focus / 04 May 2022

Henry Zakumumpa from Makerere University School of Public Health airs his research on HIV care and treatment strategies in Uganda and the need for more robust pharmacovigilance.


With the right care, people infected with HIV can lead long and healthy lives. But as with any life-long medical treatment, it is important to acknowledge and manage any side effects.  

In the latest episode of Drug Safety Matters, Henry Zakumumpa from Makerere University School of Public Health tells podcast host Federica Santoro about the potential harms of new HIV therapies and the challenges faced by pharmacovigilance specialists in Uganda. 

Subscribe by visiting the Drug Safety Matters website or listen in right here:

Related Articles

From Nobel prize to PV: How neural networks inspired vigiGroup

Pharmacovigilance in older adults – New podcast episode

Ecopharmacovigilance: Ensuring environmental safety from pharmaceuticals

You may also like

Ecopharmacovigilance: Ensuring environmental safety from pharmaceuticals

Pharmacovigilance monitors the safety of the medicines we use, but what about those that get into our environment?

In focus / 15 October 2024

From Nobel prize to PV: How neural networks inspired vigiGroup

Machine learning has long been used at UMC. In fact, our vigiGroup method stems from neural networks pioneered by one of this year’s Nobel laureates in Physics.

In focus / 05 December 2024

Pharmacovigilance in older adults – New podcast episode

Compared to the general population, older adults are more at risk of experiencing adverse drug reactions. Why is this the case, and what does this mean for pharmacovigilance?

In focus / 29 October 2024